Bulk order Acrobiosystems for Chinese

Chinese

A-Z

SARS-CoV-2 | CD24 | CD73 | Trimer | CD19 | PD-1

There is no goods in the shopping cart !

My Cart

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9

Home
Product & Service

Products by Category

Recombinant proteins and more
FDA DMF Filed ProteinsHot SARS-CoV-2 Related ProductsHot Immune Checkpoint ProteinsHot Targets of CAR-T Cell TherapyNew Biosimilar Drug TargetsHot Tumor MicroenvironmentHot Anti-idiotypic AntibodyHot Fc Receptor Proteins Llama IgG Fc Fusion ProteinNew Bio-Markers & CD Antigens ActiveMax -Best Cytokines Viral Proteins Enzymes Antibodies All Recombinant Proteins
Services

Innovation Lab ServicesNew SPR /BLI analytical serviceNew

Pre-labeled proteins
Biotinylated protein collectionHot FITC & PE labeled ProteinsNew Fluorescent fusion proteins
Kits
SARS-CoV-2 Related Kit ProductsNew Pre-Coupling Magnetic BeadsNew Universal ELISA KitsNew ELISA Assay Kits for Quantitative Analysis of Therapeutic Antibodies in Serum SamplesNew Inhibitor Screening Kits
Others
HPLC-verified Proteins Integrin - Integrin Proteins BCMA - B-Cell Maturation Antigen TIGIT - TIGIT Signaling Axis CD24 & Siglec-10 proteinsHot

Hot Products

Supports on COVID-19 R&D
Reagents for vaccine developmentNew Reagents for diagnostic developmentNew SARS-CoV-2 related productsNew SARS-CoV-2 related kitsNew SARS-CoV-2 spike mutantsNew
Others
Bispecific antibody targetsHot Targets for ADCsHot IL-2 ReceptorsHot CD19 proteinsHot Anti-FMC63 mAbHot CD3 proteinsHot B7 family proteinsHot TNFSF proteinsHot VEGF proteinsHot CD39/CD73 proteinsNew Siglec-15 proteinsHot CD20 proteinsExclusive PD1 proteinsHot
Support

How to Order Shipping & Payments Global Distributors Testimonials Download Brochures Download COA
Application

The Process of How SARS-CoV-2 Infects the Host Quantitative Analysis of mAb in Serum Evaluation of CAR Expression
X-LAB
Company

About Us Join Us Contact Us
Activities

News Exhibitions Promotion
COVID-19 R&D ^New

Your Position: Home > Integrin alpha V beta 3

Integrin alpha V beta 3

Integrin alpha V beta 3 Molecule Information

Name:Integrin alpha-V/beta-3
Target Synonym:Integrin alphaVbeta3

Number of Launched Drugs:0
Number of Drugs in Clinical Trials:11
Lastest Research Phase:Phase 3 Clinical

Integrin alpha V beta 3 Protein Product ListCompare or Buy

Product> Filter Results

Cat. No.	Species	Product Description	Structure	Purity	Feature
IT3-H52E3	Human	Human Integrin alpha V beta 3 (ITGAV&ITGB3) Heterodimer Protein, His Tag&Tag Free

Integrin alpha V beta 3 Part of Bioactivity data

IT3-H52E3-MALS-HPLC

Human ITGAV&ITGB3 Heterodimer Protein, His Tag&Tag FreeHuman ITGAV&ITGB3 Heterodimer Protein, His Tag&Tag Free (Cat. No. IT3-H52E3) ELISA bioactivity

Immobilized Human Fibronectin at 2 μg/mL (100 μL/well) can bind Human ITGAV&ITGB3 Heterodimer Protein, His Tag&Tag Free (Cat. No. IT3-H52E3) with a linear range of 0.01-0.313 μg/mL (QC tested).

Protocol

Integrin alpha V beta 3 Molecule Synonym Name

Integrin alpha V beta 3,ITGAV&ITGB3,ITGAV&B3

Integrin alpha V beta 3 Molecule Background

Integrin alpha-V/beta-3 (ITGAV:ITGB3) is a receptor for cytotactin, fibronectin, laminin, matrix metalloproteinase-2, osteopontin, osteomodulin, prothrombin, thrombospondin, vitronectin and von Willebrand factor. Integrins alpha-IIb/beta-3 and alpha-V/beta-3 recognize the sequence R-G-D in a wide array of ligands. Also, Integrin alpha-V/beta-3 acts as a receptor for herpes virus 8/HHV-8, coxsackievirus A9, Hantaan virus, cytomegalovirus/HHV-5, human metapneumovirus, human parechovirus 1 and west nile virus. Furthermore, in case of HIV-1 infection, the interaction with extracellular viral Tat protein seems to enhance angiogenesis in Kaposi's sarcoma lesions.

Integrin alpha V beta 3 References

Integrin alpha V beta 3 Clinical Drug Information

Name	Research Code	Research Phase	Company	Indications	Clinical Trials
Risuteganib	ALG-1001	Phase 2 Clinical	Allegro Ophthalmics	Retinal Diseases; Diabetic macular oedema; Diabetic Retinopathy; Macular Degeneration	Details
68Ga-NOTA-BBN-RGD	68Ga-NOTA-BBN-RGD	Phase 1 Clinical	Peking Union Medical College Hospital	Breast Neoplasms; Prostatic Neoplasms	Details
68Ga-NOTA-3PTATE-RGD	68Ga-NOTA-3PTATE-RGD; 68Ga-NOTA-3P-TATE-RGD	Phase 1 Clinical	Peking Union Medical College Hospital	Lung Neoplasms	Details
SF-0166	SF-0166	Phase 2 Clinical	Scifluor Life Sciences	Diabetic macular oedema; Macular Degeneration	Details
派格安替安吉肽		Phase 1 Clinical	Nanjing Anji Biological Technology Co Ltd, Jiangsu Aotexin Biomedical Technology Co Ltd, China Pharmaceutical University	Rheumatic Diseases	Details
Peptide-based PET radiotracer (Stanford University)		Phase 2 Clinical	Stanford University	Neoplasms	Details
Antiangiotide	HM-3; IIM-3	Phase 1 Clinical	Neimenggu Tianqi Mnegyao Group Co Ltd, China Pharmaceutical University	Solid tumours; Liver Neoplasms; Stomach Neoplasms; Carcinoma, Non-Small-Cell Lung	Details
IDL-2965	IDL-2965	Phase 2 Clinical	Indalo Therapeutics	Non-alcoholic Fatty Liver Disease; Idiopathic Pulmonary Fibrosis	Details
Alfatide[18F]		Phase 1 Clinical	Taizhou Kairui Pharmaceutical Technology Co Ltd, Jiangsu Smk Pharmaceutical Co Ltd	Neoplasms	Details
Abituzumab	DI-17E6; EMD-525797	Phase 2 Clinical	Merck Serono	Bone metastases; Solid tumours; Scleroderma, Systemic; Ovarian Diseases; Prostatic Neoplasms; Colorectal Neoplasms	Details
99mTc-3PRGD2	99mTc-3PRGD2	Phase 3 Clinical	Peking University	Contrast agents; Lymphatic Metastasis; Lung Neoplasms	Details
AS-101	WAX-120337; IVAX-Q-101; IVX-Q-101; CB-06-02; AS-101; PRX-001; PRX-0002/AS101; PRX-0001/AS101	Phase 2 Clinical	Biomas	Warts; Myelodysplastic Syndromes; Psoriasis; Leukemia, Myeloid, Acute; Thrombocytopenia; Macular Degeneration; Condylomata Acuminata; Dermatitis, Atopic	Details
[68Ga]-FF58		Phase 1 Clinical		Glioblastoma; Brain Neoplasms	Details